人工智能和纳米技术在疫苗开发中的应用
Yadollah Bahrami1, Mansoor Bolideei2, Sara Mohammadzadeh3
1Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran; Department of Medical Biotechnology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah 6714415185, Iran; Department of Medical Biotechnology, School of Medicine, College of Medicine and Public Health, Flinders University, Adelaide, SA 5042, Australia; Advanced Marine Biomanufacturing Laboratory, Centre for Marine Bioproducts Development, College of Medicine and Public Health, Flinders University, Adelaide, SA 5042, Australia.
人工智能 (AI) 和纳米技术正在彻底改变疫苗开发,加速制造更快,更精确,更适应的疫苗. 这些技术克服了传统的局限性,为个性化和通用疫苗铺平了道路.
科学领域:
- 疫苗学
- 生物技术
- 计算生物学
背景情况:
- 传统的疫苗开发面临着速度,成本和适应新病原体的挑战.
- 新出现的传染病需要更快,更有效的疫苗生产方法.
研究的目的:
- 研究人工智能 (AI) 和纳米技术对疫苗开发的变革性影响.
- 突出人工智能和纳米技术在克服传统疫苗开发局限性的协同效应.
主要方法:
- 利用人工智能,包括机器学习 (ML) 和深度学习 (DL),快速识别和预测免疫原抗原和表位.
- 使用纳米技术与工程纳米颗粒 (NP) 来增强抗原传递,稳定性和免疫激活.
- 整合人工智能和纳米技术用于个性化免疫策略和先进的疫苗设计,如病毒样粒子 (VLP).
主要成果:
- 人工智能算法通过分析大型生物数据集来加速抗原发现和优化疫苗设计.
- 纳米技术通过改进的输送系统和免疫刺激来提高疫苗的有效性和安全性.
- 人工智能和纳米技术的整合使个性化疫苗开发成为可能,并加速应对新出现的健康威胁.
结论:
- 人工智能和纳米技术代表了疫苗学的范式转变,使得疫苗的开发速度更快,更精确,更易于适应.
- 这种跨学科的方法支持针对各种疾病的个性化,通用和治疗性疫苗的创造.
- 人工智能和纳米技术之间的协同作用有望显著提升公共卫生准备和疾病控制.
更多相关视频
10:16Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
相关概念视频
Microorganisms in Medicine and Therapeutics
Vaccinations
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
